In a world where antibiotic resistance looms large, the return of amoxicillin to pharmacies is a timely development that offers a glimmer of hope. Once a staple in the medical community’s arsenal against bacterial infections, this widely prescribed antibiotic faced significant shortages that disrupted treatment protocols and left many patients in limbo. Now, as manufacturers…
Read More
Sanofi faces legal scrutiny as the company is placed under investigation for toxic emissions from its Mourenx facility, amidst ongoing concerns about Dépakine, a medication linked to adverse health effects. The inquiry raises critical questions about corporate responsibility.
Read More